Show simple item record

dc.contributor.authorKolyvushko, Oleksandr Hryhorovych
dc.description.abstractPorcine circovirus type 2 (PCV2) is a pathogen of swine. Vaccines against PCV2 are available, although none are capable of differentiating infected from vaccinated animals (DIVA). Positive and negative DIVA markers were introduced in the vaccine constructs. Decoy epitopes were modified by site directed mutagenesis to avoid possible subversion of host immunity and achieve a rationalized vaccine design. Immunization of pigs with the modified vaccines, followed by challenge with a virulent field strain showed that the efficacy of the vaccine was comparable to a commercial vaccine. The average weight gain was significantly higher group vaccinated with experimental construct if compared to the group that received commercial vaccine. An appropriate response to the positive and negative DIVA tags was detected. Therefore, the strategy used in this study is the first to enable a DIVA capable vaccine and accompanying immuno-assay, while using an epitope based approach to target improved immunogenicity.en_US
dc.publisherNorth Dakota State Universityen_US
dc.rightsNDSU policy 190.6.2
dc.titleA Porcine Circovirus Vaccine with Enhanced Capabilitiesen_US
dc.typeThesisen_US
dc.date.accessioned2018-04-30T19:00:59Z
dc.date.available2018-04-30T19:00:59Z
dc.date.issued2016en_US
dc.identifier.urihttps://hdl.handle.net/10365/28059
dc.identifier.orcid0000-0002-4801-5063
dc.rights.urihttps://www.ndsu.edu/fileadmin/policy/190.pdf
ndsu.degreeMaster of Science (MS)en_US
ndsu.collegeAgriculture, Food Systems and Natural Resourcesen_US
ndsu.departmentMicrobiological Sciencesen_US
ndsu.advisorRamamoorthy, Sheela


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record